Moreover, KRT17 advances carcinogenesis of skin cancer [27], non-small-cell lung cancer [22], renal cell carcinoma [28], pancreatic cancer [29], and hepatocellular carcinoma [16]. This evidence concerns the gene KRT17 and pancreatic neoplasm.